![](/img/cover-not-exists.png)
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Cornely, Oliver A., Robertson, Michael N., Haider, Shariq, Grigg, Andrew, Geddes, Michelle, Aoun, Mickael, Heinz, Werner J., Raad, Issam, Schanz, Urs, Meyer, Ralf G., Hammond, Sarah P., Mullane, KathlLanguage:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dkx263
Date:
August, 2017
File:
PDF, 320 KB
english, 2017